A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4. 8 billion.
Source: [Decrypt](https://decrypt.co/375968/moderna-stock-doubles-cancer-vaccine)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at Decrypt ↗